Full Length Research Paper
References
|
Armani A, Becker RC (2005). The biology, utilization, and attenuation of C-reactive protein in cardiovascular disease: Part II. Am. Heart J. 149(6):977-983. Crossref |
||||
|
Asegaonkar SB, Marathe A, Tekade ML, Cherekar L, Bavikar J, Bardapurkar J, Ajay R (2011). High-sensitivity C-reactive protein: a novel cardiovascular risk predictor in type 2 diabetics with normal lipid profile. J. Diab. Complication 25(6):368-370. Crossref |
||||
|
Celik T, Yuksel UC, Demirkol S, Bugan B, Iyisoy A, Kabul HK, Kilic S, Fici F, Yaman H (2011). Relationship between increased systemic inflammation and impaired aortic elasticity in young patients with prehypertension. Blood Press. Monit. 16(2):55-61. Crossref |
||||
|
Chobanian AV, Bakris GL, Black HR, Cushman WC, Green LA, Izzo JL Jr, Jones DW, Materson BJ, Oparil S, Wright JT Jr, Roccella EJ (2003). National Heart, Lung, and Blood Institute Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure, National High Blood Pressure Education Program Coordinating Committee: The Seventh Report of the Joint National Committee on prevention, detection, evaluation, and treatment of high blood pressure: The JNC 7 report. JAMA 289(19):2560-2572. Crossref |
||||
| Corrado E, Novo S (2005). Role of inflammation and infection in vascular disease. Acta Chir. Belg. 105(6):567-579. | ||||
|
Fantuzzi G (2005). Adipose tissue, adipokines, and inflammation. J. Allergy Clin. Immunol. 115(5):911-919. Crossref |
||||
| Horowitz LG (2008). Reference intervals: practical aspects. Electronic J. Int. Fed. Clin. Chem. Lab. Med. 19(2):1-11. | ||||
|
Kougias P, Chai H, Lin PH, Yao Q, Lumsden AB, Chen C (2005). Effects of adipocyte-derived cytokines on endothelial functions: implication of vascular disease. J. Surg. Res. 126(1):121-129. Crossref |
||||
| Moreno-Aliaga MJ, Campion J, Milagro FI, Berjon A, Martinez JA (2005). Adiposity and proinflammatory state: The chicken or the egg. Adipocytes 1:1-16. | ||||
| Nakapong R, Meerit S (2006). Cardiovascular diseases report in 2006. Department of Disease Control, Ministry of Public Health, Thailand. | ||||
|
Pearson TA, Mensah GA, Alexander, RW Anderson JL, Cannon RO 3rd, Criqui M, Fadl YY, Fortmann SP, Hong Y, Myers GL, Rifai N, Smith SC Jr, Taubert K, Tracy RP, Vinicor F (2003). Markers of inflammation and cardiovascular disease: Application to clinical and public health practice: A statement for healthcare professionals from the Centers for Disease Control and Prevention and the American Heart Association. Circulation 107(3):499-511. Crossref |
||||
|
Pu LJ, Lu L, Xu XW, Zhang RY, Zhang Q, Zhang JS, Hu J, Yang ZK, Ding FH, Chen QJ, Lou S, Shen J, Fang DH, Shen WF (2006). Value of serum glycated albumin & high-sensitivity C-reactive protein levels in the prediction of presence of coronary artery disease in patients with type 2 diabetes. Cardiovasc. Diabetol. 5:27. Crossref |
||||
|
Ridker PM (1998). Inflammation, infection, and cardiovascular risk: How good is the clinical evidence? Circulation 97(17):1671-1674. Crossref |
||||
|
Ridker PM (2003). Clinical application of C-reactive protein for cardiovascular disease detection and prevention. Circulation 107(3):363-369. Crossref |
||||
|
Rogowski O, Shapira I, Toker S, Melamed S, Shirom A, Zeltser D, Berliner S (2007). Very low C-reactive protein in apparently healthy individuals: Physiological status or just a reflection of an improved health profile. Biomarkers 12(6):645-656. Crossref |
||||
|
Soriano-Guillén L, Hernández-García B, Pita J, Domínguez-Garrido N, Del Río-Camacho G, Rovira A (2008). High-sensitivity C-reactive protein is a good marker of cardiovascular risk in obese children and adolescents. Eur. J. Endocrinol. 159(1):R1-4. Crossref |
||||
|
Vettor R, Milan G, Rossato M, Federspil G (2005). Adipocytokines and insulin resistance. Aliment. Pharmacol. Ther. 22(Suppl 2):3-10. Crossref |
||||
|
Xu H, Barnes GT, Yang Q, Tang G, Yang D, Chou CJ, Sole J, Nichols A, Ross JS, Tartaglia LA, Chen H (2003). Chronic inflammation in fat plays a crucial role in the development of obesity-related insulin resistance. J. Clin. Invest. 112(12):1821-1830. Crossref |
||||
Copyright © 2024 Author(s) retain the copyright of this article.
This article is published under the terms of the Creative Commons Attribution License 4.0
